Louise Dinsmore, RPH | |
48 East Broadway, Derry, NH 03038 | |
(603) 434-2600 | |
Not Available |
Full Name | Louise Dinsmore |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 48 East Broadway, Derry, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538615133 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 3219 (New Hampshire) | Primary |
183500000X | Pharmacist | PH24610 (Massachusetts) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Louise Dinsmore, RPH 48 East Broadway, Derry, NH 03038 Ph: (603) 434-2600 | Louise Dinsmore, RPH 48 East Broadway, Derry, NH 03038 Ph: (603) 434-2600 |
News Archive
Researchers at The Scripps Research Institute (TRSI) are fueling the future of cancer treatment by improving a powerful tool in disease defense: the body's immune system. By revealing a novel but widespread cell signaling process, the scientists may have found a way to manipulate an important component of the immune system into more effectively fighting disease.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Johnson & Johnson (NYSE: JNJ) and its subsidiary Centocor Ortho Biotech Inc., today announced that the companies have reached agreement to amend the distribution rights to REMICADE and SIMPONI, which treat chronic inflammatory diseases such as rheumatoid arthritis.
Late Monday afternoon, the co-chairmen of the congressional super committee announced that their talks had ended in stalemate. In a joint statement, Sen. Patty Murray, D-Wash., and Rep. Jeb Hensarling, R-Texas, said, "After months of hard work and intense deliberations, we have come to the conclusion today that it will not be possible to make any bipartisan agreement available to the public before the committee's deadline."
When Elyse Imamura's son was an infant, she and her husband, Robert, chose to spread out his vaccinations at a more gradual pace than the official schedule recommended.
Kronos Longevity Research Institute (KLRI) has announced plans for the Kronos Early Estrogen Prevention Study (KEEPS), a five-year study of female hormone replacement therapy aimed at providing prospective data on the risks and benefits of early menopausal hormonal intervention, particularly as it relates to the progression of atherosclerosis. Atherosclerosis is a medical condition in which fatty material is deposited along the walls of arteries.
› Verified 2 days ago
Joseph Doucette, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 48 E Broadway, Derry, NH 03038 Phone: 603-434-2600 | |
Frank Eugene Garland V, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 48 E Broadway, Derry, NH 03038 Phone: 603-434-2600 | |
Dr. Eric John Landry, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 48 East Broadway, Derry, NH 03038 Phone: 603-434-2600 | |
Ms. Karen L Coupe, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 Crystal Ave, Derry, NH 03038 Phone: 603-437-9799 Fax: 603-437-5642 | |
Amelia Anna Jarosz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17 Crystal Ave, Derry, NH 03038 Phone: 603-423-9330 | |
Valerie Tay, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 55 Crystal Ave, Derry, NH 03038 Phone: 603-437-9654 | |
Amina Gusic, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 Crystal Ave, Derry, NH 03038 Phone: 603-437-9799 |